Larry Todd Edwards, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), bought 1,093 shares at $7.11 ($8K) on 2024-11-30, disclosed to the SEC on 2024-12-03.
Open-market purchase of $8k ARQT by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ARQT | SELL | 2025-11-10 | $1.5M | — | Filing → |
| ARQT | SELL | 2025-10-06 | $174K | — | Filing → |
| ARQT | SELL | 2025-05-20 | $210K | — | Filing → |